+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Therapeutics Market by Technology Platform, Therapeutic Application, Delivery Method - Global Forecast to 2030- Product Image
mRNA Therapeutics Market by Technology Platform, Therapeutic Application, Delivery Method - Global Forecast to 2030- Product Image
Sale

mRNA Therapeutics Market by Technology Platform, Therapeutic Application, Delivery Method - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666329
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA therapeutics market is shaping a new era in targeted disease treatment, offering novel approaches across diverse therapeutic areas and rapidly advancing platform technologies. Senior decision-makers navigating this dynamic landscape require actionable intelligence and strategic clarity to stay ahead.

Market Snapshot: mRNA Therapeutics Market Size & Growth

The mRNA therapeutics market grew from USD 41.99 billion in 2024 to USD 52.59 billion in 2025. It is expected to continue expanding at a CAGR of 24.78%, reaching USD 158.60 billion by 2030. This significant trajectory reflects both sustained R&D and accelerated adoption in multiple disease areas.

Scope & Segmentation

This report delivers a comprehensive breakdown of the current mRNA therapeutics landscape, focusing on platform innovations, regional momentum, and application diversity. Segmentation includes:

  • Technology Platforms: Lipid nanoparticles, polymer-based systems, and viral vectors are driving differentiated delivery solutions and enabling broader clinical application.
  • Therapeutic Applications: Focus areas span cardiovascular, infectious diseases, oncology, and rare diseases, each showcasing unique research priorities and evolving competitive dynamics.
  • Delivery Methods: Intramuscular, intravenous, and subcutaneous administration provide tailored options for dosing and site-of-care considerations, improving patient experience and program feasibility.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific. Regional analyses address regulatory trends, funding environments, and local manufacturing capabilities driving adoption.
  • Companies Profiled: Market leaders and innovators such as Moderna, Inc., BioNTech SE, CureVac N.V., Sanofi S.A., Pfizer Inc., GlaxoSmithKline plc, Arcturus Therapeutics Holdings, Inc., Providence Therapeutics Holdings Inc., Ethris GmbH, and eTheRNA immunotherapies NV.

Key Takeaways for Senior Decision-Makers

  • Platform innovation is expanding the therapeutic scope of mRNA technologies, moving beyond infectious disease into oncology, cardiovascular, and rare genetic conditions.
  • Strategic partnerships between biotechnology companies, academic centers, and contract service providers streamline the transition from research to clinical validation and accelerate innovation cycles.
  • Supply chain resilience and geographic diversification have become essential, with companies adapting sourcing strategies to manage emerging cost pressures and policy shifts.
  • Regulatory agencies are implementing adaptive frameworks and expedited pathways, supporting faster clinical trial approvals and focused on ongoing safety and real-world evidence.
  • Advances in delivery systems—such as lipid nanoparticles and engineered viral vectors—enable precise tissue targeting and scalable manufacturing.
  • Regional clusters and public-private collaborations in North America, Europe, and Asia-Pacific foster talent retention, infrastructure investment, and competitive differentiation.

Assessing Tariff Impact on the mRNA Therapeutics Market

Recent US tariffs on biopharmaceutical components are influencing costs and strategic priorities in the mRNA supply chain. Manufacturers are diversifying suppliers, exploring domestic partnerships, and investing in localized manufacturing to offset tariff-induced risks and maintain production continuity. These adaptations may affect pricing negotiations and contract dynamics as companies balance reshoring incentives with operational complexity.

Methodology & Data Sources

This analysis leverages primary interviews with industry leaders and regulators, together with secondary research from scientific literature, clinical trial databases, and market activity tracking. A rigorous approach to data triangulation and validation underpins the reliability of segmentation and trend insights.

Why This Report Matters

  • Enable targeted innovation by providing detailed breakdowns of technology and delivery trends for executive decision-making.
  • Mitigate operational and regulatory risks through up-to-date analysis of evolving policies and supply chain strategies.
  • Support strategic alliances and investments with current profiles of key industry players and growth drivers across regions.

Conclusion

The mRNA therapeutics market is rapidly evolving, shaped by innovation, regional momentum, and regulatory adaptation. Forward-looking strategies anchored in technological diversification and cross-sector collaboration will be critical to optimizing growth and sustained competitiveness in this sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. mRNA Therapeutics Market, by Technology Platform
8.1. Introduction
8.2. Lipid Nanoparticles
8.3. Polymer Based
8.4. Viral Vectors
9. mRNA Therapeutics Market, by Therapeutic Application
9.1. Introduction
9.2. Cardiovascular
9.3. Infectious Diseases
9.4. Oncology
9.5. Rare Diseases
10. mRNA Therapeutics Market, by Delivery Method
10.1. Introduction
10.2. Intramuscular
10.3. Intravenous
10.4. Subcutaneous
11. Americas mRNA Therapeutics Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa mRNA Therapeutics Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific mRNA Therapeutics Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Moderna, Inc.
14.3.2. BioNTech SE
14.3.3. CureVac N.V.
14.3.4. Sanofi S.A.
14.3.5. Pfizer Inc.
14.3.6. GlaxoSmithKline plc
14.3.7. Arcturus Therapeutics Holdings, Inc.
14.3.8. Providence Therapeutics Holdings Inc.
14.3.9. Ethris GmbH
14.3.10. eTheRNA immunotherapies NV
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. MRNA THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. MRNA THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. MRNA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MRNA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MRNA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MRNA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MRNA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MRNA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. CANADA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 28. CANADA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 30. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 31. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 44. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 46. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 47. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 49. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 50. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 52. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 53. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 55. ITALY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 56. ITALY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ITALY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 58. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 59. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 61. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 62. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 64. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 65. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 67. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 68. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 70. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 71. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 76. QATAR MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 77. QATAR MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. QATAR MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 79. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 80. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 82. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 83. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 85. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 86. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 88. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 89. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 91. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 92. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 97. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 98. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 100. POLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 101. POLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. POLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 103. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 104. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. CHINA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 111. CHINA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. CHINA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 113. INDIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 114. INDIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. INDIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 116. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 117. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 128. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 129. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 143. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 146. MRNA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 147. MRNA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this mRNA Therapeutics market report include:
  • Moderna, Inc.
  • BioNTech SE
  • CureVac N.V.
  • Sanofi S.A.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Arcturus Therapeutics Holdings, Inc.
  • Providence Therapeutics Holdings Inc.
  • Ethris GmbH
  • eTheRNA immunotherapies NV

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 52.59 Billion
Forecasted Market Value ( USD ) by 2030 $ 158.6 Billion
Compound Annual Growth Rate24.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

mRNA Therapeutics - Global Strategic Business Report - Product Image

mRNA Therapeutics - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report - Product Image

mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report

  • Report
  • 166 Pages
  • Global
From
mRNA Therapeutics Market Report 2025 - Product Image

mRNA Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mrna Therapeutics Contract Development & Manufacturing Organization Market by Application, by Indication, by End-user, and by Region - Product Image

Mrna Therapeutics Contract Development & Manufacturing Organization Market by Application, by Indication, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
2024 Global Forecast for Mrna Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Mrna Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From

About the mRNA Therapeutics Market

The mRNA Therapeutics market is a subset of the larger Genomics market, which focuses on the development of therapeutics based on messenger RNA (mRNA). mRNA is a type of genetic material that is used to produce proteins in cells. mRNA Therapeutics are designed to target specific diseases by delivering mRNA molecules to cells, which can then be used to produce proteins that can treat or prevent the disease. mRNA Therapeutics have the potential to revolutionize the way diseases are treated, as they can be used to target specific diseases without affecting other parts of the body. The mRNA Therapeutics market is still in its early stages, but is expected to grow rapidly in the coming years. Companies in the market are focused on developing mRNA-based therapeutics for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders. Some of the companies in the mRNA Therapeutics market include Moderna, CureVac, Arcturus Therapeutics, and BioNTech. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.